201 related articles for article (PubMed ID: 11469692)
1. Microvessel density in pituitary adenomas and carcinomas.
Vidal S; Kovacs K; Horvath E; Scheithauer BW; Kuroki T; Lloyd RV
Virchows Arch; 2001 Jun; 438(6):595-602. PubMed ID: 11469692
[TBL] [Abstract][Full Text] [Related]
2. Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior.
Vidal S; Kovacs K; Horvath E; Rotondo F; Kuroki T; Lloyd RV; Scheithauer BW
Mod Pathol; 2002 Nov; 15(11):1205-12. PubMed ID: 12429800
[TBL] [Abstract][Full Text] [Related]
3. Microvascular structural entropy: a novel approach to assess angiogenesis in pituitary tumors.
Vidal S; Horvath E; Kovacs K; Lloyd RV; Scheithauer BW
Endocr Pathol; 2003; 14(3):239-47. PubMed ID: 14586069
[TBL] [Abstract][Full Text] [Related]
4. Microvessel density and area in pituitary microadenomas.
Jasek E; Furgal-Borzych A; Lis GJ; Litwin JA; Rzepecka-Wozniak E; Trela F
Endocr Pathol; 2009; 20(4):221-6. PubMed ID: 19705298
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of RCAS1 in human pituitary adenomas.
Umeoka K; Sanno N; Oyama K; Tahara S; Kurotani R; Ikuyama S; Nakashima M; Watanabe T; Osamura RY; Teramoto A
Mod Pathol; 2001 Dec; 14(12):1232-6. PubMed ID: 11743045
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas.
Niveiro M; Aranda FI; Peiró G; Alenda C; Picó A
Hum Pathol; 2005 Oct; 36(10):1090-5. PubMed ID: 16226108
[TBL] [Abstract][Full Text] [Related]
7. Expression of hypoxia-inducible factor-1alpha (HIF-1alpha) in pituitary tumours.
Vidal S; Horvath E; Kovacs K; Kuroki T; Lloyd RV; Scheithauer BW
Histol Histopathol; 2003 Jul; 18(3):679-86. PubMed ID: 12792878
[TBL] [Abstract][Full Text] [Related]
8. Endoglin and CD-34 immunoreactivity in the assessment of microvessel density in normal pituitary and adenoma subtypes.
Rotondo F; Sharma S; Scheithauer BW; Horvath E; Syro LV; Cusimano M; Nassiri F; Yousef GM; Kovacs K
Neoplasma; 2010; 57(6):590-3. PubMed ID: 20845998
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 expression in human pituitary tumors.
Vidal S; Kovacs K; Bell D; Horvath E; Scheithauer BW; Lloyd RV
Cancer; 2003 Jun; 97(11):2814-21. PubMed ID: 12767095
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis in pituitary adenomas and the normal pituitary gland.
Turner HE; Nagy Z; Gatter KC; Esiri MM; Harris AL; Wass JA
J Clin Endocrinol Metab; 2000 Mar; 85(3):1159-62. PubMed ID: 10720055
[TBL] [Abstract][Full Text] [Related]
11. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.
Thapar K; Scheithauer BW; Kovacs K; Pernicone PJ; Laws ER
Neurosurgery; 1996 Apr; 38(4):765-70; discussion 770-1. PubMed ID: 8692397
[TBL] [Abstract][Full Text] [Related]
12. A comparative analysis of ESM-1 and vascular endothelial cell marker (CD34/CD105) expression on pituitary adenoma invasion.
Miao Y; Zong M; Jiang T; Yuan X; Guan S; Wang Y; Zhou D
Pituitary; 2016 Apr; 19(2):194-201. PubMed ID: 26809958
[TBL] [Abstract][Full Text] [Related]
13. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and growth fractions of pituitary adenomas.
Yonezawa K; Tamaki N; Kokunai T
Surg Neurol; 1997 Nov; 48(5):494-500. PubMed ID: 9352815
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between tumor blood vessels heterogeneity and hormonal profile of pituitary adenomas: evidence and controversies.
Bălinişteanu B; Cimpean AM; Melnic E; Coculescu M; Ceauşu RA; Raica M
Anticancer Res; 2014 Oct; 34(10):5413-20. PubMed ID: 25275036
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis in pituitary adenomas.
Yamada S; Takada K
Microsc Res Tech; 2003 Feb; 60(2):236-43. PubMed ID: 12539178
[TBL] [Abstract][Full Text] [Related]
17. The characteristics of incidental pituitary microadenomas in 120 Korean forensic autopsy cases.
Kim JH; Seo JS; Lee BW; Lee SY; Jeon SH; Lee KB
J Korean Med Sci; 2007 Sep; 22 Suppl(Suppl):S61-5. PubMed ID: 17923757
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of angiogenesis in 77 pituitary adenomas using endoglin as a marker.
Pizarro CB; Oliveira MC; Pereira-Lima JF; Leães CG; Kramer CK; Schuch T; Barbosa-Coutinho LM; Ferreira NP
Neuropathology; 2009 Feb; 29(1):40-4. PubMed ID: 18673444
[TBL] [Abstract][Full Text] [Related]
19. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
[TBL] [Abstract][Full Text] [Related]
20. Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumour behaviour.
Turner HE; Nagy Z; Gatter KC; Esiri MM; Wass JA; Harris AL
Br J Cancer; 2000 Apr; 82(8):1441-5. PubMed ID: 10780524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
